Donald Wuchterl

Direttore/Membro del Consiglio presso ABEONA THERAPEUTICS INC.

Patrimonio netto: 239 815 $ in data 30/04/2024

54 anni

Health Technology

Consumer Services

Posizioni attive di Donald Wuchterl

Società	Posizione	Inizio	Fine
ABEONA THERAPEUTICS INC.	Direttore/Membro del Consiglio	19/04/2021	-
ABEONA THERAPEUTICS INC.	Independent Dir/Board Member	19/04/2021	-
T-Knife Therapeutics, Inc.	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
AUDENTES THERAPEUTICS, INC.	Corporate Officer/Principal	01/01/2016	01/01/2021
Cytovance Biologics, Inc. Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK.	Direttore operativo	-	-

Fitchburg State University	Masters Business Admin
Colorado Technical University, Inc.	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	2
Director/Board Member	1
Independent Dir/Board Member	1

Settori

Health Technology	4
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ABEONA THERAPEUTICS INC.	Health Technology

Aziende private	3
Astellas Gene Therapies, Inc. Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA.	Health Technology
Cytovance Biologics, Inc. Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK.	Health Technology
T-Knife Therapeutics, Inc.